我国医药电商相关法律机制研究.pdfVIP

2009 233 221 ·理论探讨 · 王轶超, 田　侃＊ (, 　210046) :　 提出了完善我国医药电子商务规制的设想。在分析目前我国医药电子商务B to B、 B to C 模式存在的法 问题的基础上, 讨论了国外医药电子商务相关法 问题的处理及对我国的启示。 中国政府应发挥宏观调控和指导作用, 制定和完善符合新的经济活动发展规 的法 措施, 引 导中国的医药电子商务健康快速发展。 :　医药电子商务;法 规制;交易平台 :F062.5;D922.16　　: 　　:1002-7777 (2009)03-0221-05 Study of Law and Regulation of ChinesePharmaceutical E-commerce and Its Development Foreground Wang Yichao and Tian Kan (Economic and Trade School of Management, Nanjing Traditional Chinese Medicine University, Nanjing 210046) ABS RAC 　Objective To put forward the assumption of perfecting law and regulation of Chinese pharma- ceutical e-commerce.Methods In the analysis of the legal problems existing in Chinese B to B and B to C pharmaceutical e-commerce, research the legal problemsdisposal of western developed countriespharma- ceutical e-commerce and revelation for our country .Results and Conclusions The Chinese government should play the role of macro-control and guidance, constitute and perfect the legal measures in line with the rules of the development of new economic activities, and induct healthy and rapid development of Chi- nese pharmaceutical e-commerce. KEY WORDS　pharmaceutical e-commerce;law and regulation;transaction platform 　　, to Business); 、 , B to C (Business to Customer)。 , B to B 。 , 。 (、 、、 ) 10%。 , 、 、 , B to B [1-2] 、 ; 200% 。 。 , 、 、 、、 , 。 , D、 H、 PlanetR , 。 , 1　 。, B , : to C , , , B to B (Business () :, ;T el:61423068583;E-mail:wangbob0303@ :, , ;T el:(025E-mail:tiankane @ 222 2009 23 3 , 1000 , 2　 [2-4] 2000 。